The CYP2C9 polymorphism: from enzyme kinetics to clinical dose recommendations

Author： Kirchheiner Julia   Tsahuridu Martina   Jabrane Wafaa   Roots Ivar   Brockmööller Jüürgen  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.1, Iss.1, 2004-12, pp. : 63-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Influence of NSAIDs on Coumarin Sensitivity in Patients with CYP2C9 Polymorphism After Total Hip Replacement Surgery

By Beinema Maarten J.  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 2, 2007-01 ,pp. : 123-128

Adis International

Access to resources Recommend Favorite

Evaluation of the effect of quercetin treatment on CYP2C9 enzyme activity of diclofenac in healthy human volunteers

By  

PHYTOTHERAPY RESEARCH, Vol. 32, Iss. 2, 2018-02 ,pp. : 305-311

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 5, 2014-11 ,pp. : 542-548

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical significance of CYP2C9‐status guided valproic acid therapy in children

By  

EPILEPSIA, Vol. 56, Iss. 6, 2015-06 ,pp. : 849-855

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of CYP2C9 polymorphism on the fall in International Normalized Ratio in patients interrupting warfarin therapy before elective surgery

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 8, 2015-08 ,pp. : 1436-1440

John Wiley & Sons Inc

Access to resources Recommend Favorite